FDA's final guidance clarifies reprint guidelines
Pharma Compliance Alert, February 11, 2009
In January, the FDA provided some much needed guidance for the pharmaceutical industry about when companies can properly distribute reprints containing information about off-label and investigational uses of products.
According to the guidance, companies can distribute a scientific or medical journal article or reference publication that addresses scientifically sound clinical investigations. Articles must be in the form of an unabridged reprint, copy of an article, or reference publication and accompanied by the approved labeling and a comprehensive bibliography.
Download our free white paper, FDA Finalizes Guidance on Distribution of Reprints, for more information about the guidance.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- COT basics to best
- Searched
